CPIX · NASDAQ · Drug Manufacturers - Specialty & Generic

Cumberland Pharmaceuticals (CPIX)

Develops ifetroban for rare-disease complications while retaining a life-sciences venture interest.

$6.90
Pre-market+0.37 (+5.67%)
At close$6.53(−0.46%)

Breakdown13F · 13D/G · Form 4

Institutions34 holders · as of Mar 31, 202618.43%2.76M shares
Insiders7 holders · as of Mar 20, 202641.20%6.17M shares
Otherremainder40.37%6.05M shares

14.98M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
A. J. KazimiInsiderdirector, 10 percent owner, officer: Chairman and CEO
38.01%5.70MForm 4filed Mar 18, 2026
Ikarian Capital, LLCInstitution
3.69%553,15313Fas of Mar 31, 2026
Renaissance Technologies LLCInstitution
3.14%470,69613Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
2.41%361,75913Fas of Mar 31, 2026
Kenneth KrogulskiInsiderdirector
2.02%302,338Form 4filed Mar 20, 2026
Dimensional Fund Advisors LPInstitution
1.84%276,35913Fas of Mar 31, 2026
Perceptive Advisors LLCInstitution
1.31%196,97813Fas of Mar 31, 2026
Bridgeway Capital Management, LLCInstitution
1.09%163,46813Fas of Mar 31, 2026
Boothbay Fund Management, LLCInstitution
0.85%127,69413Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution
0.76%114,29313Fas of Mar 31, 2026
J. Goldman & Co LPInstitution
0.54%81,04013Fas of Mar 31, 2026
Joseph C. GalanteInsiderdirector
0.42%63,656Form 4filed Mar 20, 2026
Bank of New York Mellon CorpInstitution
0.39%58,45813Fas of Mar 31, 2026
BlackRock, Inc.Institution
0.38%56,89113Fas of Mar 31, 2026
James JonesInsiderdirector
0.31%46,863Form 4filed Mar 20, 2026
Vanguard Fiduciary Trust CoInstitution
0.30%45,62313Fas of Mar 31, 2026
Acadian Asset Management LLCInstitution
0.30%44,28813Fas of Mar 31, 2026
State Street CorpInstitution
0.26%39,51013Fas of Mar 31, 2026
Marex Group PLCInstitution
0.24%36,42313Fas of Mar 31, 2026
Caroline YoungInsiderdirector
0.23%35,109Form 4filed Mar 20, 2026
XTX Topco LtdInstitution
0.16%24,00613Fas of Mar 31, 2026
Arrowstreet Capital, Limited PartnershipInstitution
0.14%20,25213Fas of Mar 31, 2026
John M. HammInsiderofficer: VP Chief Financial Officer
0.13%20,073Form 4filed Mar 18, 2025
Northern Trust CorpInstitution
0.13%19,60313Fas of Mar 31, 2026
Cresset Asset Management, LLCInstitution
0.13%19,47513Fas of Mar 31, 2026

13F — a manager's quarterly holdings · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

34 holders · 2.76M shares · 7 new positions · 13 increased · 10 reduced · 6 closed

HolderShares% outstandingChg q/qFiled
Ikarian Capital, LLC553.2K3.69%−2.8KMay 15, 2026
Renaissance Technologies LLC470.7K3.14%−1.5KMay 14, 2026
Vanguard Capital Management LLC361.8K2.41%+361.8KnewMay 15, 2026
Dimensional Fund Advisors LP276.4K1.84%+4.1KMay 7, 2026
Perceptive Advisors LLC197.0K1.31%−144.1KMay 29, 2026
Bridgeway Capital Management, LLC163.5K1.09%0May 15, 2026
Boothbay Fund Management, LLC127.7K0.85%−813May 15, 2026
Geode Capital Management, LLC114.3K0.76%+7.0KMay 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
A.J. Kazimi38.40%5.79M13GFeb 9, 2026

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 1, 2025
Kenneth Krogulskidirector
Purchase68$3.44288,413
Aug 4, 2025
Kenneth Krogulskidirector
Purchase68$4.01288,481
Aug 5, 2025
Kenneth Krogulskidirector
Purchase68$3.92288,549
Aug 6, 2025
Kenneth Krogulskidirector
Purchase68$3.34288,617
Aug 7, 2025
Kenneth Krogulskidirector
Purchase68$3.14288,685
Aug 8, 2025
Kenneth Krogulskidirector
Purchase68$3.39288,753
Aug 11, 2025
Kenneth Krogulskidirector
Purchase68$2.87288,821
Aug 12, 2025
Kenneth Krogulskidirector
Purchase68$2.91288,889
Aug 13, 2025
Kenneth Krogulskidirector
Purchase68$2.94288,957
Aug 14, 2025
Kenneth Krogulskidirector
Purchase68$2.84289,025

CongressHouse and Senate disclosures

Not reported.